Geron (GERN) Operating Leases (2019 - 2026)
Geron's (GERN) quarterly Operating Leases came in at $1.2 million in Q1 2026, down 40.74% year-on-year from $2.1 million in Q1 2025, and down 15.16% quarter-over-quarter from $1.4 million in Q4 2025.
Geron (GERN) Operating Leases (2019 - 2026) Analysis & Trends
Geron has disclosed Operating Leases across 8 years of filings, most recently posting $1.2 million for Q1 2026.
- Operating Leases for Q1 2026 came in at $1.2 million, down 40.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 40.74% YoY), and the FY2025 annual result was $1.4 million, down 36.23% from the prior year.
- Operating Leases came in at $1.2 million for Q1 2026 at Geron, down from $1.4 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $4.1 million in Q1 2022 to a low of $1.2 million in Q1 2026.
- The 5-year median for Operating Leases is $2.8 million (2024), against an average of $2.8 million.
- Across the five-year window, Operating Leases retreated 11.71% in 2022 and sank 40.74% in 2026, its largest moves.
- Geron's Operating Leases stood at $3.7 million in 2022, then dropped by 18.11% to $3.0 million in 2023, then fell by 24.62% to $2.3 million in 2024, then slumped by 36.23% to $1.4 million in 2025, then decreased by 15.16% to $1.2 million in 2026.
- The last three Operating Leases figures came in at $1.2 million (Q1 2026), $1.4 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 1.66 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 3.01 Mn |
| Sep 30, 2023 | 3.18 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 3.67 Mn |
| Sep 30, 2022 | 3.83 Mn |
| Jun 30, 2022 | 3.98 Mn |
| Mar 31, 2022 | 4.13 Mn |
| Dec 31, 2021 | 4.27 Mn |
| Sep 30, 2021 | 4.41 Mn |
| Jun 30, 2021 | 4.54 Mn |